CN Stock MarketDetailed Quotes

688393 Guangzhou LBP Medicine Science & Technology

Watchlist
  • 18.28
  • +0.09+0.49%
Market Closed May 15 15:00 CST
1.71BMarket Cap42.51P/E (TTM)

About Guangzhou LBP Medicine Science & Technology Company

The company was founded in 2005 and is the first listed company in the field of pathological diagnosis in China. It integrates R&D, production, marketing, service and education, and has built four major businesses: tumor screening, tumor diagnosis, digital pathology, and pathology services. The company is mainly engaged in R&D, production and sales of pathological diagnostic reagents and instruments. The main products are in vitro diagnostic reagents and diagnostic instruments. Company honors: Municipal Industrial Design Center, High-tech Enterprise, Guangzhou Clean Production Enterprise, etc.

Company Profile

Short Name-A安必平医药
Company NameGuangzhou LBP Medicine Science & Technology Co., Ltd.
Listing DateAug 20, 2020
Issue Price30.56
Shares Offered23.34M share(s)
FoundedJul 6, 2005
Chairmanxiangting cai
Legal Representativexiangting cai
CEOxiangting cai
Secretaryquanneng hou
Employees907
ProvinceGuang Dong Sheng
Phone020-32210051
Office AddressNo. 2 Kexin Street, Fengxin Road, Science City, Huangpu District, Guangzhou
Zip Code510663
Registered AddressNo. 2 Kexin Street, Fengxin Road, Science City, Huangpu District, Guangzhou, Guangdong
Fax020-32290284
Emailzqswb@gzlbp.com
Business License914401017756768239
BusinessThe company is mainly engaged in R&D, production and sales of in vitro diagnostic reagents and instruments, and is a high-tech enterprise with independent R&D and innovation capabilities.

Company Executives

  • Name
  • Position
  • Salary
  • xiangting cai
  • Chairman,directors,general manager,Core technical personnel
  • 965.10K
  • zongsheng liang
  • directors
  • 693.50K
  • haijiao wang
  • directors
  • --
  • hongri wu
  • Independent directors
  • 80.00K
  • xiang wu
  • Independent directors
  • 80.00K
  • wenping peng
  • Independent directors
  • --
  • kun du
  • Securities affairs representative
  • --
  • shangcan lin
  • auditors
  • 308.90K
  • quanneng hou
  • Chief Financial Officer
  • 665.30K
  • zhenwu peng
  • Core technical personnel
  • 838.60K
  • junxuan zhu
  • Core technical personnel
  • --
  • zhongchun su
  • Core technical personnel
  • --
  • mianqiao chen
  • Core technical personnel
  • --
  • wuke chen
  • Core technical personnel
  • 789.20K
  • shaoyu chen
  • Core technical personnel
  • 525.50K
  • zhefeng deng
  • Director of Marketing
  • 800.90K
  • xinru jin
  • Employee supervisors
  • 363.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg